OppenheimerFunds’s Hologic HOLX Stock Holding History

OppenheimerFunds’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$294K	Sell	6,070 -1,727	-22%	-$77.9K	﹤0.01%	1556
2018 Q4	$320K	Buy	7,797 +521	+7%	+$21.4K	﹤0.01%	1540
2018 Q3	$298K	Buy	7,276 +136	+2%	+$5.5K	﹤0.01%	1661
2018 Q2	$284K	Sell	7,140 -224	-3%	-$8.62K	﹤0.01%	1658
2018 Q1	$275K	Sell	7,364 -215,355	-97%	-$8.7M	﹤0.01%	1632
2017 Q4	$9.52M	Sell	222,719 -111,990	-33%	-$4.47M	0.01%	741
2017 Q3	$12.3M	Sell	334,709 -199,334	-37%	-$8.05M	0.02%	712
2017 Q2	$24.2M	Buy	534,043 +156,151	+41%	+$6.89M	0.03%	498
2017 Q1	$16.1M	Buy	377,892 +90,435	+31%	+$3.69M	0.02%	643
2016 Q4	$11.5M	Buy	287,457 +280,103	+3,809%	+$10.8M	0.01%	731
2016 Q3	$286K	Sell	7,354 -1,041	-12%	-$39.3K	﹤0.01%	1514
2016 Q2	$290K	Sell	8,395 -654,489	-99%	-$22.7M	﹤0.01%	1479
2016 Q1	$22.9M	Sell	662,884 -49,114	-7%	-$1.71M	0.03%	520
2015 Q4	$27.5M	Sell	711,998 -19,953	-3%	-$776K	0.04%	474
2015 Q3	$28.6M	Sell	731,951 -247,959	-25%	-$9.83M	0.04%	451
2015 Q2	$37.3M	Sell	979,910 -950	-0.1%	-$33.3K	0.04%	418
2015 Q1	$32.4M	Buy	+980,860	New	+$30.1M	0.04%	473

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OppenheimerFunds's HOLX Position: Q1 2019 in Review

OppenheimerFunds reduced its Hologic (HOLX) stake by 22% in Q1 2019, selling an estimated $77.9K and leaving 6,070 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

OppenheimerFunds first reported a position in HOLX in Q1 2015 and has held it in 17 quarters since. The position peaked at $37.3M in Q2 2015. 467 funds tracked by Wall St. Rank hold HOLX as of Q1 2019.

OppenheimerFunds held 6,070 shares of Hologic worth $294K as of Q1 2019.
OppenheimerFunds sold 1,727 Hologic shares in Q1 2019, an estimated $77.9K.
Hologic made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1556 holding.
OppenheimerFunds first reported a position in Hologic in Q1 2015 and has held it in 17 quarters since.
OppenheimerFunds's Hologic position peaked at $37.3M in Q2 2015.
467 funds tracked by Wall St. Rank held Hologic as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.